Anti-FHOD3/ FHOS2/ Formactin2 functional antibody

Anti-FHOD3/ FHOS2/ Formactin2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FHOD3/FHOD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1501-Ab-1/ GM-Tg-hg-SE1501-Ab-2Anti-Human FHOD3 monoclonal antibodyHuman
GM-Tg-rg-SE1501-Ab-1/ GM-Tg-rg-SE1501-Ab-2Anti-Rat FHOD3 monoclonal antibodyRat
GM-Tg-mg-SE1501-Ab-1/ GM-Tg-mg-SE1501-Ab-2Anti-Mouse FHOD3 monoclonal antibodyMouse
GM-Tg-cynog-SE1501-Ab-1/ GM-Tg-cynog-SE1501-Ab-2Anti-Cynomolgus/ Rhesus macaque FHOD3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1501-Ab-1/ GM-Tg-felg-SE1501-Ab-2Anti-Feline FHOD3 monoclonal antibodyFeline
GM-Tg-cang-SE1501-Ab-1/ GM-Tg-cang-SE1501-Ab-2Anti-Canine FHOD3 monoclonal antibodyCanine
GM-Tg-bovg-SE1501-Ab-1/ GM-Tg-bovg-SE1501-Ab-2Anti-Bovine FHOD3 monoclonal antibodyBovine
GM-Tg-equg-SE1501-Ab-1/ GM-Tg-equg-SE1501-Ab-2Anti-Equine FHOD3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1501-Ab-1/ GM-Tg-hg-SE1501-Ab-2; GM-Tg-rg-SE1501-Ab-1/ GM-Tg-rg-SE1501-Ab-2;
GM-Tg-mg-SE1501-Ab-1/ GM-Tg-mg-SE1501-Ab-2; GM-Tg-cynog-SE1501-Ab-1/ GM-Tg-cynog-SE1501-Ab-2;
GM-Tg-felg-SE1501-Ab-1/ GM-Tg-felg-SE1501-Ab-2; GM-Tg-cang-SE1501-Ab-1/ GM-Tg-cang-SE1501-Ab-2;
GM-Tg-bovg-SE1501-Ab-1/ GM-Tg-bovg-SE1501-Ab-2; GM-Tg-equg-SE1501-Ab-1/ GM-Tg-equg-SE1501-Ab-2
Products NameAnti-FHOD3 monoclonal antibody
Formatmab
Target NameFHOD3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FHOD3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1501-Ag-1Recombinant multi-species FHOD3/ FHOS2/ Formactin2 protein


    Target information

    Target IDGM-SE1501
    Target NameFHOD3
    Gene ID80206,225288,100360334,709762,480157,101098341,785433,100067548
    Gene Symbol and SynonymsA930009H06Rik,CMH28,FHOD3,FHOS2,Formactin2,mKIAA1695
    Uniprot AccessionQ2V2M9
    Uniprot Entry NameFHOD3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000134775
    Target ClassificationN/A

    The target: FHOD3, gene name: FHOD3, also named as FHOS2, Formactin2. The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQS™1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.